An experimental treatment developed from cattle plasma for Middle East respiratory syndrome (MERS) coronavirus infection shows broad potential, according to a small clinical trial. The treatment, SAB-301, was safe and well tolerated by healthy volunteers, with only minor reactions documented.
from Latest Science News -- ScienceDaily http://ift.tt/2FmWQ34
via IFTTT
Home »
» MERS antibodies produced in cattle safe, treatment well tolerated in phase 1 trial
0 comments:
Post a Comment